Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Ne… (NCT07207122) | Clinical Trial Compass
RecruitingNot Applicable
Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases
United States20 participantsStarted 2025-10-08
Plain-language summary
The purpose of this study is to evaluate the safety and efficacy of transcranial focused ultrasound neuromodulation in improving neural function, cognitive and behavioral performance, and quality of life for patients with neurodegenerative diseases.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Age 18-80 years
Ability to read and understand English
Clinical diagnosis of Alzheimer's, Parkinson's, Parkinson's dementia, mild cognitive impairment
Normal or corrected to normal vision and hearing
Must be medically stable as determined by investigators
Exclusion Criteria:
History of significant neurological disorders unrelated to the target disease
Implanted medical devices or metal implants incompatible with TUS or MRI
Uncontrolled heart or cardiac conditions or implants: severe arrhythmia, myocardial infarction, arterial angina
Psychiatric Conditions: individuals diagnosed with obsessive-compulsive disorder, psychosis, and/or bipolar disorder. Final eligibility will be determined after a thorough evaluation by the study clinicians.
Brain surgery, history of significant brain injury, seizures, or drug use deemed likely to interfere with participant safety or the experiment
Medications or drugs: A comprehensive review of current medications will be conducted by the study team. Medications known to significantly increase the risk of seizures or interact with study interventions will be carefully evaluated for safety. Final decisions on eligibility regarding medication use will be made by the study clinicians and/or PIs.
No other recreational drug use for at least 1 month prior to first treatment session
History of epilepsy: the prospective participant has had multiple seizures. If they have had one febrile seizure, provoked seizure, or acut…